NCT05145192

Brief Summary

To determine the validity of the K5 metabolic system breath-by-breath analysis setting during a high intensity treadmill running protocol compared to the criterion ParvoMedics TrueOne® 2400 automated metabolic gas analysis system. To determine the test-retest reliability of the K5 metabolic system breath-by-breath analyzer during a high intensity treadmill protocol (Bruce Protocol).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2021

Completed
12 days until next milestone

Study Start

First participant enrolled

November 29, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 6, 2021

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2023

Completed
Last Updated

January 22, 2025

Status Verified

October 1, 2024

Enrollment Period

1.9 years

First QC Date

November 17, 2021

Last Update Submit

January 20, 2025

Conditions

Outcome Measures

Primary Outcomes (6)

  • Oxygen consumption (VO2), mL/min

    Using metabolic cart, VO2 will be recorded.

    At first assessment, during week one.

  • Oxygen consumption (VO2), mL/min

    Using metabolic cart, VO2 will be recorded.

    At second assessment, during week two.

  • Oxygen consumption (VO2), mL/min

    Using metabolic cart, VO2 will be recorded.

    At third assessment, during week three.

  • Carbon dioxide production (VCO2), mL/min

    Using metabolic cart, VCO2 will be recorded.

    At first assessment, during week one.

  • Carbon dioxide production (VCO2), mL/min

    Using metabolic cart, VCO2 will be recorded.

    At second assessment, during week two.

  • Carbon dioxide production (VCO2), mL/min

    Using metabolic cart, VCO2 will be recorded.

    At third assessment, during week three.

Secondary Outcomes (21)

  • Respiratory Exchange Ratio (RER)

    At first assessment, during week one.

  • Respiratory Exchange Ratio (RER)

    At second assessment, during week two.

  • Respiratory Exchange Ratio (RER)

    At third assessment, during week three.

  • Minute Ventilation, L/min

    At first assessment, during week one.

  • Minute Ventilation, L/min

    At second assessment, during week two.

  • +16 more secondary outcomes

Study Arms (2)

COSMED K5 CPET

EXPERIMENTAL

Participants in this arm will complete the CPET using the COSMED K5 wearable metabolic system at first visit and the ParvoMedics TrueOne® 2400 automated metabolic gas analysis system at second visit.

Device: COSMED K5 CPET (Cardiopulmonary Exercise Test)Device: ParvoMedics CPET

ParvoMedics CPET

ACTIVE COMPARATOR

Participants in this arm will complete the CPET using the ParvoMedics TrueOne® 2400 automated metabolic gas analysis system at first visit and the COSMED K5 wearable metabolic system at second visit.

Device: COSMED K5 CPET (Cardiopulmonary Exercise Test)Device: ParvoMedics CPET

Interventions

In this randomized crossover trial of eligible adults, we will compare peak measurements of oxygen consumption (VO2) and carbon dioxide production (VCO2) during three maximal cardiopulmonary stress exercise tests (CPET), each seven to ten days apart. Subjects will be randomized into either the K5 or ParvoMedics (PM) group for their first CPET using a 1:1 randomization scheme and will serve as their own control in the subsequent test seven to ten days after the previous one. After both a K5 and a PM CPETs have been completed, the participants will complete an additional K5 CPET for test-retest reliability. A within-subjects analysis will be performed.

COSMED K5 CPETParvoMedics CPET

ParvoMedics CPET

COSMED K5 CPETParvoMedics CPET

Eligibility Criteria

Age20 Years - 29 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years of age

You may not qualify if:

  • Pregnancy
  • Children
  • Inmates
  • Neuromotor, musculoskeletal, or rheumatoid disorders that are exacerbated by exercise or conditions preventing cooperation
  • Contraindications to Symptom-limited Maximal Exercise Testing
  • Metabolic disease
  • Pacemakers/Implantable devices
  • Supplemental Oxygen use
  • Diagnosis of severe arterial hypertension
  • Uncontrolled asthma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baylor Scott and White Sports Therapy and Research

Frisco, Texas, 75034, United States

Location

MeSH Terms

Conditions

Motor Activity

Interventions

Exercise Test

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisRespiratory Function TestsDiagnostic Techniques, Respiratory SystemErgometryInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Center Director - The STAR at Frisco

Study Record Dates

First Submitted

November 17, 2021

First Posted

December 6, 2021

Study Start

November 29, 2021

Primary Completion

October 10, 2023

Study Completion

October 10, 2023

Last Updated

January 22, 2025

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations